In brief
The settlement aims to provide significant funding for opioid addiction treatment and prevention, marking a major step in addressing the devastating impact of opioid addiction across the country.
Purdue Pharma, the company previously attributed to the proliferation of opioid addiction in the United States, along with the Sackler family that controlled it, has reached a monumental settlement of up to $7.4 billion (£6 billion). This financial agreement comes as a response to numerous claims surrounding their infamous prescription painkiller, OxyContin, which has been a significant contributor to the opioid epidemic.This new settlement marks an increase of over $1 billion from a previous agreement dismissed by the US Supreme Court in 2024. The Sacklers have committed to providing up to $6.5 billion, while Purdue's contribution amounts to $900 million. The New York Attorney General's office confirmed that the funds will be utilized to support addiction treatment and prevention measures nationwide.Purdue expressed satisfaction with the new arrangement, stating it would help victims and initiatives aimed at alleviating the opioid crisis. "We are extremely pleased that a new agreement has been reached that will deliver billions of dollars to compensate victims, abate the opioid crisis, and deliver treatment and overdose rescue medicines that will save lives," they noted. Court approval is necessary for the settlement to take effect, and some details require further consideration.Previous negotiations had granted the Sacklers immunity from lawsuits in exchange for a $6 billion payment, but this provision has now changed. The current legal barrier shielding Sackler family members from lawsuits is scheduled to expire soon, yet requests have been made to maintain it through February as final arrangements are completed.Victims of the opioid crisis, like Kara Trainor, who battled addiction for 17 years following back surgery, expressed their hope for closure provided by the settlement. “Everything in my life is shaped by a company that put profits over human lives,” she revealed, highlighting the personal toll of the epidemic.Purdue Pharma rose to prominence as the manufacturer and promoter of OxyContin, marketed as a safe option despite knowledge of its addictive nature. Since the drug's introduction in 1999, opioid overdose fatalities have skyrocketed, leading to tens of thousands of deaths annually. Court documents suggest the Sackler family was aware of the risks after withdrawing approximately $11 billion from the company prior to its bankruptcy, making recovery of those funds complicated.
